World's Best Scientists 2026 revealed!

D-Index & Metrics

Best Female Scientists

D-Index
107
Citations
59462
World Ranking
1001
National Ranking
605

Molecular Biology

D-Index
107
Citations
60387
World Ranking
406
National Ranking
233

Carol Prives publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Carol Prives sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 278 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Carol Prives D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Carol Prives sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 107 D-Index — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

  • 2020 - Fellow of the Royal Society, United Kingdom
  • 2008 - Member of the National Academy of Sciences
  • 2005 - Member of the National Academy of Medicine (NAM)
  • 2001 - Fellow of the American Academy of Microbiology DNA Viruses
  • 2000 - Fellow of the American Academy of Arts and Sciences

Overview

Carol Prives is affiliated with Columbia University in the United States. Their research spans multiple fields, with a primary focus on biochemistry, genetics, molecular biology, and medicine. The subfields of their work include molecular biology, oncology, cancer research, pulmonary and respiratory medicine, and biotechnology.

The main topics covered by Carol Prives' research include cancer-related molecular pathways, RNA modifications and cancer, epigenetics and DNA methylation, ferroptosis and cancer prognosis, cancer research and treatments, cancer lipids and metabolism, and ubiquitin and proteasome pathways.

Carol Prives has published extensively, contributing notably to journals such as Cancer Research, Genes & Development, Cancer Discovery, bioRxiv (Cold Spring Harbor Laboratory), and Proceedings of the National Academy of Sciences.

  • MDM2 and MDMX promote ferroptosis by PPARα-mediated lipid remodeling (2020, Genes & Development)
  • GLS2 Is a Tumor Suppressor and a Regulator of Ferroptosis in Hepatocellular Carcinoma (2022, Cancer Research)
  • The roles and regulation of MDM2 and MDMX: it is not just about p53 (2021, Genes & Development)
  • p21 can be a barrier to ferroptosis independent of p53 (2020, Aging)
  • p53 at the crossroads of tumor immunity (2024, Nature Cancer)

The scientist frequently collaborates with a number of coauthors, including Gizem Efe, Rafaela Muniz de Queiroz, Anil K. Rustgi, James J. Manfredi, and David Tong.

Carol Prives' contributions have been recognized by several honors. These include being a Fellow of the Royal Society in the United Kingdom since 2020, a Member of the National Academy of Sciences since 2008, and a Member of the National Academy of Medicine since 2005. Earlier distinctions include being named a Fellow of the American Academy of Microbiology in 2001 for work related to DNA viruses and a Fellow of the American Academy of Arts and Sciences since 2000.

Best Publications

  • Blinded by the Light: The Growing Complexity of p53

    Karen H. Vousden;Carol Prives

  • p53: puzzle and paradigm.

    L J Ko;C Prives

  • Enchanced phosphorylation of P53 by ATM in response to DNA damage

    Yosef Shiloh;Nehama I. Smorodinsky

  • DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2

    Sheau-Yann Shieh;Masako Ikeda;Yoichi Taya;Carol Prives

  • The p53 pathway

    Carol Prives;Peter A. Hall

  • Mutant p53: one name, many proteins

    William A. Freed-Pastor;Carol Prives

  • Identification of p53 as a sequence-specific DNA-binding protein

    Scott E. Kern;Kenneth W. Kinzler;Arthur Bruskin;David Jarosz

  • A role for ATR in the DNA damage-induced phosphorylation of p53

    Randal S. Tibbetts;Kathryn M. Brumbaugh;Josie M. Williams;Jann N. Sarkaria

  • The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites

    Sheau-Yann Shieh;Jinwoo Ahn;Katsuyuki Tamai;Yoichi Taya

  • p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells.

    Xinbin Chen;Linda J. Ko;Lata Jayaraman;Carol Prives

  • Regulation of p53 activity through lysine methylation

    Sergei Chuikov;Julia K. Kurash;Jonathan R. Wilson;Bing Xiao

  • SIGNALING TO P53 : BREAKING THE MDM2-P53 CIRCUIT

    Carol Prives

  • Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRB is a critical determinant in blocking DNA replication and in preventing endoreduplication

    Alexander B. Niculescu;Xinbin Chen;Monique Smeets;Ludger Hengst

  • Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway

    William A. Freed-Pastor;Hideaki Mizuno;Xi Zhao;Anita Langerød

  • Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species

    Sawako Suzuki;Tomoaki Tanaka;Masha V. Poyurovsky;Hidekazu Nagano

  • E1A signaling to p53 involves the p19(ARF) tumor suppressor.

    Elisa de Stanchina;Mila E. McCurrach;Frederique Zindy;Sheau-Yann Shieh

  • Wild-type p53 activates transcription in vitro

    George Farmer;Jill Bargonetti;Hua Zhu;Paula Friedman

  • Transcriptional regulation by p53.

    Rachel Beckerman;Carol Prives

  • PML is induced by oncogenic ras and promotes premature senescence

    Gerardo Ferbeyre;Elisa de Stanchina;Emmanuelle Querido;Nicole Baptiste

  • Transcriptional regulation by p53: one protein, many possibilities.

    O Laptenko;C Prives

Frequent Co-Authors

James L. Manley
James L. Manley Columbia University
Scott W. Lowe
Scott W. Lowe Memorial Sloan Kettering Cancer Center
Xinbin Chen
Xinbin Chen University of California, Davis
Yoichi Taya
Yoichi Taya National University of Singapore
James J. Manfredi
James J. Manfredi Icahn School of Medicine at Mount Sinai
Moshe Oren
Moshe Oren Weizmann Institute of Science
Carlos Cordon-Cardo
Carlos Cordon-Cardo Icahn School of Medicine at Mount Sinai
Arnold J. Levine
Arnold J. Levine Institute for Advanced Study
Anne Lise Børresen-Dale
Anne Lise Børresen-Dale Oslo University Hospital
Harmen J. Bussemaker
Harmen J. Bussemaker Columbia University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Molecular Biology, there are several online degree options and career pathways that offer flexibility and accelerated learning. Many students explore roles in healthcare, such as nursing, which can complement a science background. If you’re considering advanced nursing roles, it’s important to understand how to become a nurse practitioner, including the education and licensing steps involved.

For registered nurses aiming to expand their qualifications quickly, there are rn to bsn 6 months programs designed for busy professionals who want to fast-track their academic journey. Similarly, those with an associate degree in nursing can benefit from programs like asn to np programs, which streamline the transition to advanced practice roles.

Additionally, career-changers with non-nursing backgrounds can pursue online direct entry msn pathways. These programs provide opportunities to enter the nursing profession and leverage your scientific knowledge for impactful healthcare careers. Whether you want to stay within molecular biology or branch into allied health fields, online educational options make career advancement more accessible than ever.

Best Scientists Citing Carol Prives

Trending Scientists

Recently Published Articles